Due to significant differences in liver pathways across species, in vitro models of the human liver are increasingly being utilised to screen for the potential efficacy, metabolism and/or toxicity of candidate compounds.
Cultures of primary human hepatocytes are widely considered to be the “gold standard” for creating such models.
Researcher Salman Khetani, from the Department of Bioengineering at the University of Illinois at Chicago (UIC), USA, will discuss the following topics during the webinar:
- Tips and best practices for the short- and long-term culture of primary human hepatocytes
- The utility of primary human hepatocytes cultures for assessing drug clearance, drug metabolite identification, and drug-transporter interactions, etc.
Date: Tuesday, 21 March 2017
- 9:00 PDT (Los Angeles)
- 12:00 EDT (New York)
- 16:00 PM GMT (London)
- 17:00 CET (Berlin)
Speaker: Salman Khetani, Ph.D. Associate Professor, Bioengineering, UIC.
Anyone interested in attending the webinar can register by clicking this link.
Those unable to join the hepatocytes webinar are invited to visit the hepatocytes product page for further information.
Alternatively, by registering interest in the webinar, participants will receive a link once it is available to view “on demand” via the Lonza website.
